This newsletter is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed
Myth: Glutathione is equally effective for everyone
Patience with titration pays off
GLP-1RAs and co-agonists have shown promising outcomes in the clinical management of MASLD
Under the short-term program, called the Medicare GLP-1 Bridge, Medicare will cover GLP-1s approved for weight reduction Wegovy and Zepbound for eligible beneficiaries enrolled in Medicare Part D for a $50 copayment
Sessions are quick, require no special preparation or downtime, and allow you to return to your daily routine immediately